Ricciuti B.; Mira A.; Andrini E.; Scaparone P.; Michelina S.V.; Pecci F.; Cantini L.; De Giglio A.; Lamberti G.; Ambrogio C.; Metro G., How to manage KRAS G12C-mutated advanced non-small-cell lung cancer, «DRUGS IN CONTEXT», 2022, 11, pp. 1 - 11 [articolo]
Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelsomino F., Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies, «IMMUNOTHERAPY», 2022, 14, pp. 1329 - 1340 [articolo]
Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D.; Lamberti G., Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, Article number: 1461, pp. 1461 - 1478 [articolo]Open Access
Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; Casadei R.; Campana D., Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis, «CANCER MEDICINE», 2022, 11, pp. 4204 - 4213 [articolo]Open Access
Giuseppe Lamberti; ANNA LA SALVIA, Neuroendocrine Tumors: Challenges and Future Perspectives, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, pp. 1 - 4 [articolo]
Pecci F.; Cantini L.; Metro G.; Ricciuti B.; Lamberti G.; Farooqi A.A.; Berardi R., Non-small-cell lung cancer: how to manage EGFR-mutated disease, «DRUGS IN CONTEXT», 2022, 11, Article number: A2, pp. 1 - 17 [articolo]
Andrini E.; Mosca M.; Galvani L.; Sperandi F.; Ricciuti B.; Metro G.; Lamberti G., Non-small-cell lung cancer: how to manage RET-positive disease, «DRUGS IN CONTEXT», 2022, 11, Article number: 2022-1-5, pp. 1 - 12 [articolo]
Cortellini A.; Ricciuti B.; Vaz V.R.; Soldato D.; Alessi J.V.; Dall'olio F.G.; Banna G.L.; Muthuramalingam S.; Chan S.; Majem M.; Piedra A.; Lamberti G.; Andrini E.; Addeo A.; Friedlaender A.; Facchinetti F.; Gorria T.; Mezquita L.; Hoton D.; Valerie L.; Nana F.A.; Artingstall J.; Comins C.; Di Maio M.; Caglio A.; Cave J.; McKenzie H.; Newsom-Davis T.; Evans J.S.; Tiseo M.; D'Alessio A.; Fulgenzi C.A.M.; Besse B.; Awad M.M.; Pinato D.J., Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2022, 10, Article number: e004374, pp. 1 - 7 [articolo]Open Access
Mollica V.; Massari F.; Andrini E.; Rosellini M.; Marchetti A.; Nuvola G.; Tassinari E.; Lamberti G.; Campana D., Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis, «CURRENT ONCOLOGY», 2022, 29, pp. 5846 - 5854 [articolo]Open Access
Ambrosini, Valentina; Zanoni, Lucia; Filice, Angelina; Lamberti, Giuseppe; Argalia, Giulia; Fortunati, Emilia; Campana, Davide; Versari, Annibale; Fanti, Stefano, Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors, «CANCERS», 2022, 14, pp. 1055 - 1083 [articolo]Open Access
Magi L.; Prosperi D.; Lamberti G.; Marasco M.; Ambrosini V.; Rinzivillo M.; Campana D.; Gentiloni G.; Annibale B.; Signore A.; Panzuto F., Role of [18F]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors, «ENDOCRINE», 2022, 76, pp. 1392 - 1399 [articolo]Open Access
Panzuto F.; Ricci C.; Rinzivillo M.; Magi L.; Marasco M.; Lamberti G.; Casadei R.; Campana D., The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, Article number: 6127, pp. 1 - 11 [articolo]Open Access
Tabacchi E.; Fortunati E.; Argalia G.; Zanoni L.; Calabro D.; Telo S.; Campana D.; Lamberti G.; Ricci C.; Casadei R.; Fanti S.; Ambrosini V., [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?, «CANCERS», 2022, 14, Article number: 3541, pp. 1 - 10 [articolo]Open Access
Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G., An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances, «PHARMACEUTICALS», 2021, 14, Article number: 316, pp. 316 - 339 [articolo]Open Access
Cortellini A.; Ricciuti B.; Facchinetti F.; Alessi J.V.M.; Venkatraman D.; Dall'Olio F.G.; Cravero P.; Vaz V.R.; Ottaviani D.; Majem M.; Piedra A.; Sullivan I.; Lee K.A.; Lamberti G.; Hussain N.; Clark J.; Bolina A.; Barba A.; Benitez J.C.; Gorria T.; Mezquita L.; Hoton D.; Aboubakar Nana F.; Besse B.; Awad M.M.; Pinato D.J., Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy, «ANNALS OF ONCOLOGY», 2021, 32, pp. 1391 - 1399 [articolo]
